Red cells, iron, and erythropoiesis: Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia

Blood

Volumn 125, Issue 4, 2015, Pages 706-709

  Dumitriu, Bogdan ^a,d   Feng, Xingmin ^a   Townsley, Danielle M ^a   Ueda, Yasutaka ^a   Yoshizato, Tetsuichi ^b   Calado, Rodrigo T ^c   Yang, Yanqin ^a   Wakabayashi, Yoshiyuki ^a   Kajigaya, Sachiko ^a   Ogawa, Seishi ^b   Zhu, Jun ^a   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d CRC 3 5216   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; APLASTIC ANEMIA; BONE MARROW CELL; CARCINOGENESIS; CHROMOSOME 7; CLINICAL ARTICLE; CLONAL EVOLUTION; CONFERENCE PAPER; EXOME; GENE MUTATION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RELAPSE; SEVERE APLASTIC ANEMIA; TELOMERE; ACUTE MYELOBLASTIC LEUKEMIA; CHROMOSOME DELETION; CLINICAL TRIAL; FEMALE; GENETICS; HEMATOPOIETIC STEM CELL; MALE; METABOLISM; PATHOLOGY; TELOMERE HOMEOSTASIS;

ANEMIA, APLASTIC; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MYELODYSPLASTIC SYNDROMES; TELOMERE HOMEOSTASIS;

EID: 84921653009     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-10-607572     Document Type: Conference Paper

References (20)

1. Scheinberg P, Young NS. How I treat acquired aplastic anemia. Blood. 2012;120(6):1185-1196.
2. Socié G, Rosenfeld S, Frickhofen N, Gluckman E, Tichelli A. Late clonal diseases of treated aplastic anemia. Semin Hematol. 2000;37(1):91-101.
3. Rosenfeld S, Follmann D, Nunez O, Young NS. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA. 2003;289(9):1130-1135.
4. Young NS. The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated. Blood. 1992;79(6):1385-1392.
5. Haferlach T, Nagata Y, Grossmann V, et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia. 2014; 28(2):241-247.
6. Welch JS, Ley TJ, Link DC, et al. The origin and evolution of mutations in acute myeloid leukemia. Cell. 2012;150(2):264-278.
7. Bejar R, Stevenson K, Abdel-Wahab O, et al. Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med. 2011;364(26): 2496-2506.
8. Scheinberg P, Cooper JN, Sloand EM, Wu CO, Calado RT, Young NS. Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia. JAMA. 2010;304(12):1358-1364.
9. Yamaguchi H, Calado RT, Ly H, et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med. 2005;352(14):1413-1424.
10. Baird DM, Rowson J, Wynford-Thomas D, Kipling D. Extensive allelic variation and ultrashort telomeres in senescent human cells. Nat Genet. 2003;33(2):203-207.
11. Deng Y, Chan SS, Chang S. Telomere dysfunction and tumour suppression: the senescence connection. Nat Rev Cancer. 2008; 8(6):450-458.
12. Chen C, Liu Y, Rappaport AR, et al. MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia. Cancer Cell. 2014;25(5): 652-665.
13. Hosono N, Makishima H, Jerez A, et al. Recurrent genetic defects on chromosome 7q in myeloid neoplasms. Leukemia. 2014;28(6):1348-1351.
14. Kulasekararaj AG, Jiang J, Smith AE, et al. Somatic mutations identify a sub-group of aplastic anemia patients that progress to myelodysplastic syndrome. Blood. 2014;pii: blood-2014-05-574889.
15. Lane AA, Odejide O, Kopp N, et al. Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia. Leukemia. 2013; 27(4):968-971.
16. Heuser M, Schlarmann C, Dobbernack V, et al. Genetic characterization of acquired aplastic anemia by targeted sequencing. Haematologica. 2014;99(9):e165-e167.
17. Calado RT, Cooper JN, Padilla-Nash HM, et al. Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia. Leukemia. 2012;26(4):700-707.
18. Artandi SE, DePinho RA. Telomeres and telomerase in cancer. Carcinogenesis. 2010; 31(1):9-18.
19. De Lange T. Telomere-related genome instability in cancer. Cold Spring Harb Symp Quant Biol. 2005;70:197-204.
20. Calado RT, Yewdell WT, Wilkerson KL, et al. Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood. 2009;114(11): 2236-2243.